Center For Asset Management LLC Makes New $740,000 Investment in Aflac Incorporated (NYSE:AFL)

Center For Asset Management LLC acquired a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,657 shares of the financial services provider's stock, valued at approximately $740,000.

Other institutional investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC acquired a new stake in Aflac during the 4th quarter worth about $26,000. BankPlus Trust Department acquired a new position in Aflac in the 4th quarter worth about $34,000. Curio Wealth LLC acquired a new position in Aflac in the 4th quarter worth about $36,000. OFI Invest Asset Management acquired a new position in Aflac in the 4th quarter worth about $38,000. Finally, Capital A Wealth Management LLC acquired a new position in Aflac in the 4th quarter worth about $38,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Performance

AFL opened at $103.31 on Friday. The firm has a market capitalization of $55.85 billion, a P/E ratio of 16.14, a price-to-earnings-growth ratio of 3.18 and a beta of 0.82. The stock's 50 day moving average price is $104.91 and its two-hundred day moving average price is $105.27. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $88.00 and a 12-month high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business's quarterly revenue was down 37.5% compared to the same quarter last year. During the same period last year, the business earned $1.66 EPS. On average, equities analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is currently 36.25%.

Insider Buying and Selling at Aflac

In other Aflac news, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the sale, the director now owns 70,992 shares of the company's stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Arthur Reginald Collins sold 2,750 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the sale, the director now directly owns 6,728 shares in the company, valued at $711,149.60. This trade represents a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock valued at $4,304,295 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on AFL shares. Wall Street Zen lowered Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Piper Sandler upped their target price on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods upped their target price on Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research report on Wednesday, May 7th. Raymond James Financial dropped their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research report on Thursday, May 29th. Finally, Morgan Stanley upped their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $104.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.